Search results for "INFORMATICS"

showing 10 items of 2542 documents

Benefits and Threats to Using Social Media for Presenting and Implementing Evidence.

2018

As a potential high-yield tool for disseminating information that can reach many people, social media is transforming how clinicians, the public, and policy makers are educated and find new knowledge associated with research-related information. Social media is available to all who access the internet, reducing selected barriers to acquiring original source documents such as journal articles or books and potentially improving implementation-the process of formulating a conclusion and moving on that decision. The use of social media for evidence dissemination/implementation of research has both benefits and threats. It is the aim of this Viewpoint to provide a balanced view of each. J Orthop…

Biomedical Research020205 medical informaticsbusiness.industryProcess (engineering)Information DisseminationInternet privacyAdministrative PersonnelPhysical Therapy Sports Therapy and Rehabilitation02 engineering and technologyGeneral MedicineResearch Personnel03 medical and health sciences0302 clinical medicineProfessionalism0202 electrical engineering electronic engineering information engineeringMedicineHumansThe InternetSocial media030212 general & internal medicineSource documentbusinessDisseminationHealth EducationSocial MediaThe Journal of orthopaedic and sports physical therapy
researchProduct

EVpedia: a community web portal for extracellular vesicles research

2014

Abstract Motivation: Extracellular vesicles (EVs) are spherical bilayered proteolipids, harboring various bioactive molecules. Due to the complexity of the vesicular nomenclatures and components, online searches for EV-related publications and vesicular components are currently challenging. Results: We present an improved version of EVpedia, a public database for EVs research. This community web portal contains a database of publications and vesicular components, identification of orthologous vesicular components, bioinformatic tools and a personalized function. EVpedia includes 6879 publications, 172 080 vesicular components from 263 high-throughput datasets, and has been accessed more tha…

Biomedical ResearchDatabases FactualComputer scienceBioactive moleculesMedizinBioinformaticsBiochemistryMathematical SciencesUser-Computer InterfaceNon-U.S. Gov'tdatabasecomputer.programming_languagePLASMAMICROPARTICLESResearch Support Non-U.S. Gov'tbioinformaticsBiological SciencesOriginal PapersCANCERComputer Science ApplicationsIdentification (information)Cell and molecular biologyComputational MathematicsComputational Theory and MathematicsPROTEOMIC ANALYSISMEMBRANE-VESICLESEXPRESSIONStatistics and ProbabilityPROSTASOMESJavaBioinformaticsexosomesResearch SupportExtracellular vesiclesWorld Wide WebDatabasesDELIVERYInformation and Computing SciencesJournal ArticleHumansMembrane vesicleMolecular BiologyFactualEXOSOMESComputational BiologyCELLSDatabase Management SystemsExtracellular SpacecomputerSoftware
researchProduct

The rise of the middle author: Investigating collaboration and division of labor in biomedical research using partial alphabetical authorship

2017

Contemporary biomedical research is performed by increasingly large teams. Consequently, an increasingly large number of individuals are being listed as authors in the bylines, which complicates the proper attribution of credit and responsibility to individual authors. Typically, more importance is given to the first and last authors, while it is assumed that the others (the middle authors) have made smaller contributions. However, this may not properly reflect the actual division of labor because some authors other than the first and last may have made major contributions. In practice, research teams may differentiate the main contributors from the rest by using partial alphabetical author…

Biomedical ResearchEconomicslcsh:MedicineSocial SciencesDatabase and Informatics MethodsMathematical and Statistical TechniquesMedicine and Health SciencesMedicinePsychologyAlphabetical orderCooperative Behaviorlcsh:ScienceLanguageMultidisciplinaryCareers05 social sciencesResearch AssessmentPublic relationsResearch PersonnelResearch DesignPublishingPhysical SciencesListing (finance)Information Technology050904 information & library sciencesSequence AnalysisStatistics (Mathematics)Period (music)Division of labourResearch ArticleEmploymentComputer and Information SciencesBioinformaticsBibliometricsResearch and Analysis Methods050905 science studiesDatabasesHumansStatistical MethodsPublishingOperationalizationbusiness.industryField (Bourdieu)lcsh:RCognitive PsychologyBiology and Life SciencesRelational DatabasesAuthorshipBibliometricsLabor EconomicsCognitive Sciencelcsh:QClinical Medicine0509 other social sciencesAttributionbusinessMathematicsForecastingNeurosciencePLOS ONE
researchProduct

Evolution of Cooperation Patterns in Psoriasis Research: Co-Authorship Network Analysis of Papers in Medline (1942–2013)

2015

BackgroundAlthough researchers have worked in collaboration since the origins of modern science and the publication of the first scientific journals in the eighteenth century, this phenomenon has acquired exceptional importance in the last several decades. Since the mid-twentieth century, new knowledge has been generated from within an ever-growing network of investigators, working cooperatively in research groups across countries and institutions. Cooperation is a crucial determinant of academic success.ObjectiveThe aim of the present paper is to analyze the evolution of scientific collaboration at the micro level, with regard to the scientific production generated on psoriasis research.Me…

Biomedical ResearchMEDLINEScienceClosenessInformation DisseminationMEDLINEBiologyBibliometricsBioinformaticsGiant componentSocial NetworkingBetweenness centralityRegional scienceHumansPsoriasisCooperative BehaviorClustering coefficientMultidisciplinarySocial networkInformation Disseminationbusiness.industryQRAuthorshipResearch PersonnelBibliometricsWorkforceMedicinePeriodicals as TopicbusinessResearch ArticlePLOS ONE
researchProduct

Gene therapy with growth factors for periodontal tissue engineering : a review

2011

The treatment of oral and periodontal diseases and associated anomalies accounts for a significant proportion of the healthcare burden, with the manifestations of these conditions being functionally and psychologically debilitating. A challenge faced by periodontal therapy is the predictable regeneration of periodontal tissues lost as a consequence of disease. Growth factors are critical to the development, maturation, maintenance and repair of oral tissues as they establish an extra-cellular environment that is conducive to cell and tissue growth. Tissue engineering principles aim to exploit these properties in the development of biomimetic materials that can provide an appropriate microen…

Biomimetic materialsPeriodontal tissuebusiness.industryGrowth factormedicine.medical_treatmentGenetic enhancementRegeneration (biology)Review-ArticleDentistryContext (language use)Genetic TherapyDiseaseBioinformatics:CIENCIAS MÉDICAS [UNESCO]OtorhinolaryngologyTissue engineeringUNESCO::CIENCIAS MÉDICASBiomaterials and Bioengineering in DentistryGuided Tissue Regeneration PeriodontalmedicineHumansIntercellular Signaling Peptides and ProteinsSurgerybusinessGeneral Dentistry
researchProduct

Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper.

2015

Extracellular vesicles (EVs), such as exosomes and microvesicles, are released by different cell types and participate in physiological and pathophysiological processes. EVs mediate intercellular communication as cell-derived extracellular signalling organelles that transmit specific information from their cell of origin to their target cells. As a result of these properties, EVs of defined cell types may serve as novel tools for various therapeutic approaches, including (a) anti-tumour therapy, (b) pathogen vaccination, (c) immune-modulatory and regenerative therapies and (d) drug delivery. The translation of EVs into clinical therapies requires the categorization of EV-based therapeutics …

Bioquímica clínicaMedizinISCHEMIA-REPERFUSION INJURYBioinformaticsimmunology; neurobiology; haematology; stem cells; tissue regeneration; tumour vaccination; regulationimmunology0302 clinical medicineClinical trialsClinical investigationVERSUS-HOST-DISEASEMedicine and Health SciencesFIELD-FLOW FRACTIONATIONMedicineImmunologiahaematology; immunology; neurobiology; regulation; stem cells; tissue regeneration; tumour vaccinationmedia_common0303 health scienceslcsh:CytologyOUTER-MEMBRANE VESICLESneurobiologyregulationHematologyBiologia experimental3. Good healthTUMOR-DERIVED EXOSOMES030220 oncology & carcinogenesistumour vaccinationDrug deliveryhaematologyPosition PaperCèl·lules mareNeurobiologiaHistologyMedicina InvestigacióCèl·lulesNANOPARTICLE TRACKING ANALYSIStissue regenerationExtracellular vesiclesMESENCHYMAL STEM-CELLS03 medical and health sciencesstem cellsJournal Articlemedia_common.cataloged_instanceREGULATORY T-CELLSEuropean unionlcsh:QH573-671ENDOTHELIAL PROGENITOR CELLSHematologia030304 developmental biologybusiness.industryCell BiologyMicrovesiclesClinical trialPosition paperPharmaceutical manufacturingUMBILICAL-CORD BLOODbusinessNeuroscienceAssaigs clínics
researchProduct

A metabolomics cell-based approach for anticipating and investigating drug-induced liver injury

2016

AbstractIn preclinical stages of drug development, anticipating potential adverse drug effects such as toxicity is an important issue for both saving resources and preventing public health risks. Current in vitro cytotoxicity tests are restricted by their predictive potential and their ability to provide mechanistic information. This study aimed to develop a metabolomic mass spectrometry-based approach for the detection and classification of drug-induced hepatotoxicity. To this end, the metabolite profiles of human derived hepatic cells (i.e., HepG2) exposed to different well-known hepatotoxic compounds acting through different mechanisms (i.e., oxidative stress, steatosis, phospholipidosis…

Bioquímica0301 basic medicineDrugmedia_common.quotation_subjectMetaboliteBiologyPharmacologymedicine.disease_causeBioinformaticsModels BiologicalArticleMass Spectrometry03 medical and health scienceschemistry.chemical_compound0302 clinical medicineMetabolomicsmedicineHumansMetabolomicsToxicologiaPhospholipidsmedia_commonPhospholipidosisMultidisciplinaryHep G2 Cellsmedicine.diseaseGlutathioneFatty LiverOxidative Stress030104 developmental biologychemistryDrug development030220 oncology & carcinogenesisToxicityChemical and Drug Induced Liver InjurySteatosisOxidative stressScientific Reports
researchProduct

Triphen­yl[(4-phenyl­benzo­yl)meth­yl]phospho­nium trifluoro­methane­sulfonate

2010

In the cation of the title compound, C32H26OP+·CF3O3S−, the dihedral angle between the benzene rings of the biphenyl group is 42.37 (8)°. In the crystal, the cations and anions interact through intermolecular C—H...O hydrogen bonds, forming chains parallel to the b axis. These chains are further linked by C—H...π stacking interactions into layers parallel to the bc plane.

BiphenylCrystallographyHydrogen bondStackingMethane sulfonateGeneral ChemistryMeth-Dihedral angleCondensed Matter PhysicsBioinformaticsMedicinal chemistryOrganic PapersCrystalchemistry.chemical_compoundchemistryQD901-999General Materials ScienceBenzeneActa Crystallographica Section E: Structure Reports Online
researchProduct

Functional Genomics of 5-to 8-Cell Stage Human Embryos by Blastomere Single-Cell cDNA Analysis

2010

Blastomere fate and embryonic genome activation (EGA) during human embryonic development are unsolved areas of high scientific and clinical interest. Forty-nine blastomeres from 5- to 8-cell human embryos have been investigated following an efficient single-cell cDNA amplification protocol to provide a template for high-density microarray analysis. The previously described markers, characteristic of Inner Cell Mass (ICM) (n = 120), stemness (n = 190) and Trophectoderm (TE) (n = 45), were analyzed, and a housekeeping pattern of 46 genes was established. All the human blastomeres from the 5- to 8-cell stage embryo displayed a common gene expression pattern corresponding to ICM markers (e.g., …

BlastomeresDNA ComplementaryScienceCell Biology/Developmental Molecular MechanismsBiologyDevelopmental Biology/Molecular DevelopmentmedicineHumansInner cell massHuman embryogenesisBlastocystCell Biology/Gene ExpressionOligonucleotide Array Sequence AnalysisDevelopmental Biology/EmbryologyMultidisciplinaryMicroarray analysis techniquesGene Expression ProfilingGenetics and Genomics/Functional GenomicsQRGenetics and Genomics/Gene ExpressionEmbryoGenomicsBlastomereGenetics and Genomics/BioinformaticsMolecular biologyEmbryonic stem cellDevelopmental Biology/Stem CellsGene expression profilingmedicine.anatomical_structureembryonic structuresMedicineResearch Article
researchProduct

GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms

2018

Type 2 diabetes mellitus (T2DM) is a metabolic condition with an elevated impact on cardiovascular (CV) risk. The innovative therapeutic approaches for T2DM - incretin-based therapies (IBTs), including glucagon-like peptide 1 (GLP-1) receptor agonists, have become popular and more widely used in recent years. The available scientific data from clinical studies and clinical practice highlights their beyond glucose-lowering effects, which is achieved without any increase in hypoglycaemia. The former effects include reduction in body weight, lipids, blood pressure, inflammatory markers, oxidative stress, endothelial dysfunction, and subclinical atherosclerosis, thus reducing and potentially pr…

Blood GlucoseCardiometabolic parameterGlucagon-Like PeptidesIncretin030209 endocrinology & metabolism030204 cardiovascular system & hematologyBioinformaticsIncretinsGlucagon-Like Peptide-1 Receptor03 medical and health sciences0302 clinical medicineDiabetes mellitusmedicineHumansHypoglycemic AgentsEndothelial dysfunctionMolecular BiologyGlucagon-like peptide 1 receptorLiraglutidebusiness.industryType 2 Diabetes MellitusLiraglutideCardiovascular riskmedicine.diseasePlaque AtheroscleroticType 2 diabetes mellituBlood pressureDiabetes Mellitus Type 2Cardiovascular DiseasesMetabolic control analysisGlucagon-like peptide 1 receptor agonistMolecular Medicinebusinessmedicine.drugBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
researchProduct